Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 14, 2019

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions

Spinal Fusion

Interventions

DRUG

Abaloparatide

80 mcg delivered SC by a pen

DRUG

Placebo

A pen to deliver a SC dose of placebo

Trial Locations (1)

RECRUITING

Hospital for Special Surgery, New York

All Listed Sponsors

lead

Hospital for Special Surgery, New York

OTHER